Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Talzenna (talazoparib) for the Treatment of Advanced Breast Cancer

Talzenna (talazoparib) is a PARP inhibitor developed for the treatment of adult patients with germline BRCA-mutated (gBRCAm) HER2-negative locally advanced or metastatic breast cancer. Image courtesy of Emw.

  • Talzenna (talazoparib)
  • Talzenna (talazoparib)
  • Talzenna (talazoparib)

Go Top